Artal International S.C.A.

CIK 000121818013 companiesTHOUSAND OAKS, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001218180

Recent Transactions

30 trades

Sale
CAVA GROUP, INC.$CAVA
Common Stock
2024-11-18$134.13/sh−8,000,000→ 9,507,990 total
Sale
CAVA GROUP, INC.$CAVA
Common Stock
2024-08-26$116.36/sh−6,000,000→ 17,507,990 total
Sale
CAVA GROUP, INC.$CAVA
Common Stock
2024-06-05$87.25/sh−3,000,000→ 23,507,990 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Series A Convertible Preferred Stock
2024-05-10−1,150,922→ 0 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Series A Convertible Preferred Stock
2024-05-10$108.50/sh+1,150,922→ 1,150,922 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2024-05-10+57,546,100→ 136,180,481 total
Sale
CAVA GROUP, INC.$CAVA
Common Stock
2024-03-21$66.25/sh−2,000,000→ 26,507,990 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Series A Convertible Preferred Stock
2024-03-13$108.50/sh+1,150,922→ 1,150,922 total
Sale
CAVA GROUP, INC.$CAVA
Common Stock
2024-02-27$53.60/sh−3,500,000→ 28,507,990 total
Exercise/Conversion
CAVA GROUP, INC.$CAVA
Series E Preferred Stock
2023-06-20−22,252,464→ 0 total
Exercise/Conversion
CAVA GROUP, INC.$CAVA
Common Stock
2023-06-20+3,486,366→ 5,055,231 total
Exercise/Conversion
CAVA GROUP, INC.$CAVA
Common Stock
2023-06-20+1,845,864→ 6,901,095 total
Exercise/Conversion
CAVA GROUP, INC.$CAVA
Series A Preferred Stock
2023-06-20−1,568,865→ 0 total
Exercise/Conversion
CAVA GROUP, INC.$CAVA
Common Stock
2023-06-20+22,252,464→ 30,014,898 total
Exercise/Conversion
CAVA GROUP, INC.$CAVA
Series C Preferred Stock
2023-06-20−1,845,864→ 0 total
Exercise/Conversion
CAVA GROUP, INC.$CAVA
Common Stock
2023-06-20+1,568,865→ 1,568,865 total
Exercise/Conversion
CAVA GROUP, INC.$CAVA
Common Stock
2023-06-20+861,339→ 7,762,434 total
Exercise/Conversion
CAVA GROUP, INC.$CAVA
Common Stock
2023-06-20+1,993,092→ 32,007,990 total
Exercise/Conversion
CAVA GROUP, INC.$CAVA
Series B Preferred Stock
2023-06-20−3,486,366→ 0 total
Exercise/Conversion
CAVA GROUP, INC.$CAVA
Series F Preferred Stock
2023-06-20−1,993,092→ 0 total
Exercise/Conversion
CAVA GROUP, INC.$CAVA
Series D Preferred Stock
2023-06-20−861,339→ 0 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-06-05$2.60/sh+27,775,050→ 78,634,381 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2022-08-05$2.50/sh+2,426,070→ 50,859,331 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2022-08-01$2.50/sh+16,173,800→ 48,433,261 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2020-12-16$3.20/sh+10,937,500→ 32,259,461 total
Conversion
Scholar Rock Holding Corp$SRRK
Common Stock
2018-05-29+1,946,040→ 1,946,040 total
Conversion
Scholar Rock Holding Corp$SRRK
Series C Preferred Stock
2018-05-29−5,555,556→ 0 total
Purchase
Scholar Rock Holding Corp$SRRK
Common Stock
2018-05-29$14.00/sh+450,000→ 450,000 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2014-11-26$1.00/sh+149,253,731→ 149,253,731 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2012-10-23$2.25/sh+3,000,000→ 283,154,744 total

Artal International S.C.A.

Recent Transactions

Companies

Recent Filings

Address